Clinical Efficacy and Safety of CD7-Targeted CAR T Cell Therapy for T-cell Malignancies: A Systematic Review and Meta-analysis.
Mohsen DashtiMohammad Amin HabibiNegar NejatiBehrouz Robat-JaziMahsa AhmadpourNegar DokhaniAida Rezaei NejadShaghayegh KaramiErfan AlinejadAmirhossein MalekijooAfsaneh GhasemzadehFarhad Jadidi-NiaraghPublished in: Anti-cancer agents in medicinal chemistry (2024)
CD7 is an active and safe target that shows promising results in the treatment of relapsed and/or refractory (r/r) T-cell malignancies.